Holte, H.
Leppa, S.
Bjorkholm, M.; et al.
|
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
Annals of Oncology,
24(5): 1385-1392
|
2013
|
-
|
d'Amore, Francesco
Relander, Thomas
Lauritzsen, Grete F.; et al.
|
Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
Journal of Clinical Oncology,
30(25): 3093-3099
|
2012
|
-
|
Kimby, Eva
Östenstad, Björn
Brown, Peter de Nully; et al.
|
Rituximab (R) in Combination with Interferon-a2a (IFN) Versus Single R in Patients with Follicular or Other CD20+Low-Grade (indolent) Lymphoma. Final Results From a Randomized Phase III Study From the Nordic Lymphoma Group
Blood,
120(21)
|
2012
|
-
|
d'Amore, Francesco
Relander, Thomas
Lauritzsen, Grete F.; et al.
|
High-dose chemotherapy and autologuos stem cell transplantation in previously untreated peripheral T-Cell Lymphoma: Final analysis of a large prospective multicenter study (NLG-T-01)
53rd ASH Annual Meeting and Exposition: 155-156
|
2011
|
-
|
Wahlin, Björn Engelbrekt
Sundström, Christer
Holte, Harald; et al.
|
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Clinical Cancer Research,
17(12): 4136-4144
|
2011
|
-
|
Pulczynski, Elisa Jacobsen
Kamper, Peter
Fagerli, Unn-Merete; et al.
|
Age-adjusted combined immunochemotherapy without radiotherapy in newly diagnosed PCNSL: A phase II trial of the Nordic Lymphoma Group
53rd ASH Anual Meeting and Exposition: 696-696
|
2011
|
-
|
Andersson, Anne
Enblad, Gunilla
Gustavsson, Anita; et al.
|
Long term risk of infections in Hodgkin lymphoma long-term survivors
British Journal of Haematology,
154(5): 661-663
|
2011
|
-
|
Linderoth, Johan
Edén, Patrik
Ehinger, Mats; et al.
|
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
Br J Haematol,
141(4): 423-432
|
2008
|
-
|
Kasteng, Frida
Erlanson, Martin
Hagberg, Hans; et al.
|
Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden.
Acta Oncol,
47(6): 1029-1036
|
2008
|
-
|
Hedström, Gustaf
Berglund, Mattias
Molin, Daniel; et al.
|
Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma.
Br J Haematol,
138(1): 68-71
|
2007
|
-
|
